Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CERUS CORPCERS · Entity 5431 | Chief Scientific Officer | March 12, 2024 | March 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CERUS CORP
Report date March 12, 2024 · Filed March 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,339,740 |
Ending reported balance
After 2024-03-14 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-12 · Exercise / conversion · Acquired 16,666 · Balance 2,368,167 F1: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Row 2 · 2024-03-13 · Sale · Disposed 14,067 · Balance 2,354,100 F2: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Row 3 · 2024-03-14 · Sale · Disposed 14,360 · Balance 2,339,740 F2: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-03-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-03-12 · Exercise / conversion · Disposed 16,666 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6: Not applicable. F5: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
F2: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
F3: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
F4: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
F5: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022.
F6: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2019 Filed Nov 4, 2019 22:56 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 13,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-055013 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 13,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| November 01, 2019 Filed Nov 4, 2019 22:56 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 13,000 | $3.75 | $48,750.00 |
DisclosureSEC source: 0001209191-19-055013 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,751,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 23:55 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-054287 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Common Stock · 12,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 23:55 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 12,000 | $3.75 | $45,000.00 |
DisclosureSEC source: 0001209191-19-054287 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,738,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2019 Filed Oct 15, 2019 20:47 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-053169 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 30,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| October 09, 2019 Filed Oct 15, 2019 20:47 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 30,000 | $3.75 | $112,500.00 |
DisclosureSEC source: 0001209191-19-053169 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,726,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 23:10 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $3.75 | Not disclosed |
DisclosureSEC source: 0001209191-19-052608 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 30,000 shares Expires 2022-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 23:10 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 30,000 | $3.75 | $112,500.00 |
DisclosureSEC source: 0001209191-19-052608 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,696,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:22 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 135,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-035790 · doc4.xml · derivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common Stock · 135,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2020. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:30 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019302 · doc4.xml · derivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,666 Underlying: Common Stock · 15,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:30 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019302 · doc4.xml · derivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:30 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019302 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,734,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 00:30 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019302 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,718,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 20:40 UTC Amendment | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 15,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019473 · doc4a.xml · derivative · entry 6 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,666 Underlying: Common Stock · 15,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 20:40 UTC Amendment | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019473 · doc4a.xml · derivative · entry 5 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 20:40 UTC Amendment | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 15,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019473 · doc4a.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,666,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 20:40 UTC Amendment | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019473 · doc4a.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,651,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 10, 2019 Filed Mar 14, 2019 00:30 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019302 · doc4.xml · derivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2019 Filed Mar 14, 2019 00:30 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019302 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 10, 2019 Filed Mar 14, 2019 20:40 UTC Amendment | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019473 · doc4a.xml · derivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2019 Filed Mar 14, 2019 20:40 UTC Amendment | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-019473 · doc4a.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 23:56 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 35,000 | Not disclosed Strike: $4.19 | Not disclosed |
DisclosureSEC source: 0001209191-18-044110 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2018-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| July 25, 2018 Filed Jul 26, 2018 23:56 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 35,000 | $4.19 | $146,650.00 |
DisclosureSEC source: 0001209191-18-044110 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,637,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2018 Filed Mar 15, 2018 21:25 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 32,100 | $5.27 | $169,282.56 |
DisclosureSEC source: 0001209191-18-019907 · doc4.xml · nonDerivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,602,591 F4 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 21:25 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 17,911 | $5.19 | $92,958.09 |
DisclosureSEC source: 0001209191-18-019907 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570,491 F3 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.23 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 21:25 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 90,000 | $5.13 | $461,475.00 |
DisclosureSEC source: 0001209191-18-019907 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,552,580 F2 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:27 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · derivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:27 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,452,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2018 Filed Mar 15, 2018 21:25 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 10,000 | $4.95 | $49,483.00 |
DisclosureSEC source: 0001209191-18-019907 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462,580 F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $4.95 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:27 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · derivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:27 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,445,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 1,089 shares purchased under Issuer's Employee Stock Purchase Plan on 8/31/17. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:54 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-018104 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:54 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 95,000 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001209191-18-018104 · doc4.xml · derivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2028-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 20:01 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 16,250 | Not disclosed Strike: $2.08 | Not disclosed |
DisclosureSEC source: 0001209191-17-049158 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,250 shares Expires 2021-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| August 15, 2017 Filed Aug 16, 2017 20:01 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 16,250 | $2.08 | $33,800.00 |
DisclosureSEC source: 0001209191-17-049158 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,437,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 20:04 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 46,030 | $2.46 | $113,187.77 |
DisclosureSEC source: 0001209191-17-048743 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,421,741 F2 · price: This transaction was executed in multiple trades at prices ranging from $2.435 to $2.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 20:04 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 46,766 | $2.44 | $114,071.63 |
DisclosureSEC source: 0001209191-17-048743 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375,711 F1 · price: This transaction was executed in multiple trades at prices ranging from $2.4150 to $2.460. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 10, 2017 Filed Mar 16, 2017 00:16 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-020945 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2017 Filed Mar 16, 2017 00:16 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-020945 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,328,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes an aggregate of 3,189 shares purchased under Issuer's Employee Stock Purchase Plan on February 28, 2017. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:21 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-018079 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 01, 2017 Filed Mar 4, 2017 01:21 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-17-018079 · doc4.xml · derivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| September 22, 2016 Filed Sep 23, 2016 22:13 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 21,000 | Not disclosed Strike: $5.55 | Not disclosed |
DisclosureSEC source: 0001209191-16-142684 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires 2016-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| September 22, 2016 Filed Sep 23, 2016 22:13 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 21,000 | $5.55 | $116,550.00 |
DisclosureSEC source: 0001209191-16-142684 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 17, 2016 00:28 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionOption (Right to Buy) · Derivative | 9,000 | Not disclosed Strike: $5.55 | Not disclosed |
DisclosureSEC source: 0001209191-16-141891 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 9,000 shares Expires 2016-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested on the first day of each month thereafter. Read SEC document |
| September 15, 2016 Filed Sep 17, 2016 00:28 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 9,000 | $5.55 | $49,950.00 |
DisclosureSEC source: 0001209191-16-141891 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,298,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.